[The new anti-alcohol preparation medikhronal: changes in the level of ethanol, acetaldehyde and monoamines during the treatment of alcoholism patients]

Eksp Klin Farmakol. 1994 Jul-Aug;57(4):64-6.
[Article in Russian]

Abstract

Treating patients with stage-II alcoholism with medichronal and unithiol sharply decreases blood levels of alcohol and acetaldehyde. Medichronal restores the decreased level of norepinephrine excretion in 25% of patients and the increased level of epinephrine in 43%. The high baseline concentration of serotonin dropped in 41%, however, its level remained higher than in the controls. There was a negative correlation between the changes of ethanol concentrations and the excretion of norepinephrine. There was a direct dependence between the changes in the norepinephrine/epinephrine ratio and the serotonin concentration.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Acetaldehyde / blood*
  • Adult
  • Alcohol Deterrents / therapeutic use*
  • Alcoholism / blood
  • Alcoholism / drug therapy*
  • Alcoholism / urine
  • Biogenic Monoamines / metabolism*
  • Drug Combinations
  • Drug Evaluation
  • Ethanol / blood*
  • Formates / therapeutic use*
  • Glucose / therapeutic use*
  • Glycine / therapeutic use*
  • Humans
  • Male
  • Time Factors

Substances

  • Alcohol Deterrents
  • Biogenic Monoamines
  • Drug Combinations
  • Formates
  • medikhronal
  • Ethanol
  • Acetaldehyde
  • Glucose
  • Glycine